MyDrHank review

A six-shelf compounded telehealth catalogue with both GLP-1 molecules, a real oral tablet and one price at every dose — sold behind headline rates that are all twelve-month prepay, with the month-to-month price shown nowhere.

Est. first month

$249/mo (oral tablet, month-to-month)

Save ~82% vs brand-name

Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.

Pricing to watch. Every price this desk advertises is the twelve-month prepay rung — the month-to-month rate is printed on no page at all. The advertised "from $171/mo" tablet costs $249 month-to-month and $2,057 up front for the year; the advertised "from $240/mo" tirzepatide costs $349 month-to-month and $2,883 up front. The site's own footnote also quotes a $200/mo tirzepatide plan, and no tier costs $200.

Semaglutide: $249/mo oral tablet · $259/mo injectable (month-to-month)
Tirzepatide: $349/mo month-to-month (from $240/mo only on the 12-month prepay, $2,883 up front)
Coverage: Excludes KS, LA, MS, NM, ND and WV; no state list published on the site
Brand-name: Compounded only

The Value Score card

MyDrHank scored on our six published factors. See the methodology.

Lowest Real Price62/100

No Teaser-Rate Bait36/100

Both Molecules94/100

Nationwide Availability74/100

Easy Cancellation58/100

Reputation72/100

Why it's a deal

Both molecules fully priced across all four terms, plus a genuine daily oral tablet — not a sublingual drop
One price at every dose on the GLP-1 line, so titrating up never raises the bill (this promise is GLP-1 only; the NAD+ and sermorelin lines say pricing depends on the dose prescribed)
Prices are published before any intake quiz — you can price the program without handing over your details first
Clean against the FDA warning-letter database under brand, entity and domain; LegitScript-approved with a live verify link, and "Dr. Hank, LLC" is credited as the operator in the privacy policy and terms

Read the fine print

⚠ Every advertised price is the twelve-month prepay rung. Month-to-month is $349 tirzepatide, $259 injectable semaglutide, $249 oral tablet — around 45% above the headline, and printed on no page of the site
The pricing footnote advertises "$200/mo for compounded tirzepatide" — a rate that exists at no tier the site sells
The FAQ describes the $171 prepay rate as a plan with "no contract"; it is twelve months bought at once, $2,057 up front
Compounded only — no FDA-approved Wegovy, Ozempic, Mounjaro or Zepbound route
No served-states list is published anywhere on the site, and six states are excluded
Neither the prescriber nor the compounding pharmacy is named — a generic "U.S. board-certified clinician" and "an FDA-registered U.S. pharmacy"

The bottom line

Best for: Shoppers who will genuinely prepay a year up front, want the same price at every dose, and have read past the headline to the $349/$259/$249 month-to-month rates. A six-shelf compounded telehealth catalogue with both GLP-1 molecules, a real oral tablet and one price at every dose — sold behind headline rates that are all twelve-month prepay, with the month-to-month price shown nowhere.

Ranked #287 of 388 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Get this deal

Compare with other deals

The programs scoring closest to MyDrHank, out of 387 others we track.

Shopping MyDrHank against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs MyDrHank, and every program that undercuts or outscores it is ranked on the MyDrHank alternatives board.

More programs we track (24)

357 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from MyDrHank's own website on August 7, 2026; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on MyDrHank's site. Not medical advice; see our disclosure.

← Back to all deals